Still, the role of STAT3 and STAT5 kinase proteins, as well as their interaction in various tumor processes, are to be detailed to develop therapeutic strategies selectively blocking or activating STAT3 and/or STAT5 in hematological malignancies and other cancers. This evidence concerns the gene STAT5B and cancer.